Engineering Co-op jobs in United States
cer-icon
Apply on Employer Site
company-logo

Teva Pharmaceuticals · 7 hours ago

Engineering Co-op

Teva Pharmaceuticals is a leading manufacturer of generic medicines, committed to making good health more affordable and accessible. The Engineering Co-op position offers students the opportunity to engage in meaningful work and high-impact projects that foster professional and personal growth during the Spring 2026 semester.

BiopharmaHealth CareMedicalPharmaceutical
check
H1B Sponsor Likelynote

Responsibilities

Embark on a future with an international pharmaceuticals company, contributing your creative energy to high-impact projects from the moment you arrive through the course of this experience
You will take part in meaningful work and real-life projects that will help you grow both professionally and personally throughout the program

Qualification

Chemical EngineeringMechanical EngineeringMicrosoft OfficeIndependenceInterpersonal SkillsCommunication SkillsTime Management

Required

Enrolled in an accredited college or university program preferably pursuing a chemical, or mechanical engineering degree
Strong interpersonal and communication skills will be required to engage with other departments within the site
Strong time management skills
Proficient in Microsoft Office programs (Word, Visio, Project)
Works independently and receives minimal guidance

Company

Teva Pharmaceuticals

company-logo
Teva Pharmaceuticals is a pharmaceutical company that develops generic and innovative medicines.

H1B Sponsorship

Teva Pharmaceuticals has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (7)
2024 (4)
2023 (23)
2022 (48)
2021 (31)
2020 (33)

Funding

Current Stage
Public Company
Total Funding
$5.51B
Key Investors
Royalty PharmaBerkshire Hathaway
2026-01-11Post Ipo Equity· $500M
2025-05-20Post Ipo Debt· $2.3B
2023-11-13Post Ipo Equity· $100M

Leadership Team

leader-logo
Dipankar Bhattacharjee
President & CEO: Generics Europe
linkedin
leader-logo
Richard Francis
President and Chief Executive Officer
linkedin
Company data provided by crunchbase